Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome

World Journal of Surgery

Volumn 33, Issue 10, 2009, Pages 2087-2093

  Bhargav, Panchagan R K ^a   Mishra, Anjali ^a   Agarwal, Gaurav ^a   Agarwal, Amit ^a   Verma, Ashok Kumar ^a   Mishra, Saroj Kanta ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DANAZOL; ERYTHROPOIETIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROLACTIN; TAMOXIFEN; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY TITER; ARTICLE; BREAST DISCHARGE; BREAST DISEASE; BREAST FIBROADENOMA; CANCER SURGERY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; EUTHYROIDISM; FEMALE; FOLLOW UP; GOITER; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MASTALGIA; OUTCOME ASSESSMENT; PREVALENCE; PROLACTIN BLOOD LEVEL; PROSPECTIVE STUDY; THYROID CANCER; THYROID DISEASE; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BREAST DISEASES; COMORBIDITY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; THYROXINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349330664     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0143-y     Document Type: Article

References (25)

1. MB Barton JG Elmore SW Fletcher 1999 Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome Ann Intern Med 130 651 657
2. C Dawson MW Armstrong J Michaels 1993 Breast disease and the general surgeon. II. Effect of audit on the referral of patients with breast problems Ann R Coll Surg Engl 75 83 86 (Pubitemid 23089470)
3. C Goehring A Morabia 1997 Epidemiology of benign breast disease, with special attention to histologic types Epidemiol Rev 19 310 327
4. F Peters W Schuth B Scheurich 1984 Serum prolactin levels in patients with fibrocystic breast disease Obstet Gynecol 64 381 385
5. S Watt-Boolsen PC Eskildsen H Blaehr 1985 Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast Cancer 56 500 502
6. JP Minton H Abou-Issa 1989 Nonendocrine theories of the etiology of benign breast disease World J Surg 13 680 684
7. DA Adamopoulos S Vassilaros N Kapolla 1986 Thyroid disease in patients with benign and malignant mastopathy Cancer 57 125 128
8. E Giustarini A Pinchera P Fierabracci 2006 Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery Eur J Endocrinol 154 645 649
9. S Venturi 2001 Is there a role for iodine in breast diseases? Breast 10 379 382
10. WR Ghent BA Eskin DA Low 1993 Iodine replacement in fibrocystic disease of the breast Can J Surg 36 453 460
11. NC Estes 1981 Mastodynia due to fibrocystic disease of the breast controlled with thyroid hormone Am J Surg 42 764 766
12. WH Goodson DH Moore 2002 Overall clinical breast examination as a factor in delayed diagnosis of breast cancer Arch Surg 137 1152 1156
13. MI Surks E Ortiz GH Daniels 2004 Subclinical thyroid disease: scientific review and guidelines for diagnosis and management JAMA 291 228 238
14. RE Mansel NJ Fenn EL Davies 1998
15. F Delange S Bastiani M Benmiloud 1986
16. PP Saraiva NB Figueiredo CR Padovani 2005 Profile of thyroid hormones in breast cancer patients Braz J Med Biol Res 38 761 765
17. SG Shering AP Zbar M Moriarty 1996 Thyroid disorders and breast cancer Eur J Cancer Prev 5 504 506
18. M Cristofanilli Y Yamamura SW Kau 2005 Thyroid hormone and breast carcinoma: primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma Cancer 103 1122 1128
19. VR Rao A Lakshmi MD Sadhnani 2008 Prevalence of hypothyroidism in recurrent pregnancy loss in first trimester Indian J Med Sci 62 359 363
20. S Gupta PK Saha A Mukhopadhyay 2008 Prevalence of hypothyroidism and importance of cholesterol estimation in patients suffering from major depressive disorder J Indian Med Assoc 106 240 242
21. Z Baloch P Carayon B Conte-Devolx 2003 Guidelines committee, national academy of clinical biochemistry: laboratory medicine practice guidelines-laboratory support for the diagnosis and monitoring of thyroid disease Thyroid 13 3 126
22. HJ Baskin RH Cobin DS Duick 2002 American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism Endocr Pract 8 457 469
23. MP Vanderpump WH Tunbridge JM French 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey Clin Endocrinol (Oxf) 43 55 68
24. GR Wilson RW Curry 2005 Subclinical thyroid disease Am Fam Physician 72 1517 1524
25. T Arrigo M Wasniewska G Crisafulli 2008 Subclinical hypothyroidism: the state of the art J Endocrinol Invest 31 79 84